APA aipamena

Kobayashi, Y., Wada, H., Rossios, C., Takagi, D., Charron, C., Barnes, P. J., & Ito, K. (2013). A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition. Blackwell Publishing Ltd.

Chicago Style aipamena

Kobayashi, Y., H. Wada, C. Rossios, D. Takagi, C. Charron, P J. Barnes, and K. Ito. A Novel Macrolide/fluoroketolide, Solithromycin (CEM-101), Reverses Corticosteroid Insensitivity Via Phosphoinositide 3-kinase Pathway Inhibition. Blackwell Publishing Ltd, 2013.

MLA aipamena

Kobayashi, Y., et al. A Novel Macrolide/fluoroketolide, Solithromycin (CEM-101), Reverses Corticosteroid Insensitivity Via Phosphoinositide 3-kinase Pathway Inhibition. Blackwell Publishing Ltd, 2013.